Comparing two valve replacement methods for small heart valves
Part of Heart & circulation clinical trials.
This trial compares two types of replacement heart valves for people with a small aortic valve opening. It aims to see which method works better for patients with this specific anatomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe narrowing of your aortic valve with symptoms (like chest pain, shortness of breath).
- Your heart valve opening is small (measured on a CT scan).
- You are scheduled to get a new valve through a catheter in your leg (not open-heart surgery).
- Your medical team agrees that this procedure is right for you.
- You can attend follow-up visits after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and effective the NAVITOR valve is for treating narrowed aortic valves placed through a catheter (no open-heart surgery). It may be an option if you’re at intermediate-to-low surgical risk and meet heart ultrasound/CT measurements.
This trial studies whether the Myval THV (a new heart valve) is safe and effective for adults who need TAVI, a procedure to replace a narrowed heart valve without open-heart surgery. You may be considered if a heart team says you’re a good candidate for this valve procedure and you’re willing to join the study.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
This trial compares two ways to treat a failing aortic valve that was replaced with a tissue valve during surgery: another surgical replacement or a less invasive catheter-based valve-in-valve procedure. It is for people with low to intermediate surgical risk who are between 18 and 75 years old.
This trial tests a newer self-expanding heart valve (Hydra) against a standard balloon-expandable valve in patients who need a replacement aortic valve because their previous surgical valve has failed. The goal is to see which approach works better and is safer for this situation.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.